Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-ALA Fluorescence Imaging in Kidney Cancer Surgery
NCT07828704Phase 2Recruiting
- Sponsor
- Henry Ford Health
- Start
- Sep 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
A Phase 2 trial of 5-aminolevulinic acid in kidney cancer, sponsored by Henry Ford Health. Started Sep 2026; status: recruiting.
02
Drugs
5-aminolevulinic acid
03
Conditions
kidney cancer
Beyond the preview
Go deeper on NCT07828704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07828704.